Clinically, as currently the most common form of HF, HFpEF is characterized by ventricular hypertrophy and myocardial fibrosis, with signs of respiratory distress and congestion in most patients [6]
However, they may be hesitent to do so as they are not trained in medication-assisted treatment
Meanwhile, depositions of Tau are also associated with ASD [351]
For example, in 2024, monthly costs for GLP-1 drugs such as Wegovy and Ozempic ranged between USD 9001,300 in the U.S., leading many patients to discontinue therapy due to financial burden
41 Evidence of Intent: Marketing materials that explicitly compare the compounded drug to Wegovy or Ozempic are used as evidence of specific intent to induce infringement of the method-of-treatment patents covering those drugs
Compounded semaglutide and tirzepatide are not FDA-approved and are used off-label for weight management